Literature DB >> 10075698

Osmotic response element is required for the induction of aldose reductase by tumor necrosis factor-alpha.

T Iwata1, S Sato, J Jimenez, M McGowan, M Moroni, A Dey, N Ibaraki, V N Reddy, D Carper.   

Abstract

Induction of aldose reductase (AR) was observed in human cells treated with tumor necrosis factor-alpha (TNF-alpha). AR protein expression increased severalfold in human liver cells after 1 day of exposure to 100 units/ml TNF-alpha. An increase in AR transcripts was also observed in human liver cells after 3 h of TNF-alpha treatment, reaching a maximum level of 11-fold at 48 h. Among the three inflammatory cytokines: TNF-alpha, interleukin-1, and interferon-gamma, TNF-alpha (100 units/ml) gave the most induction of AR. Differences in the pattern of AR induction were observed in human liver, lens, and retinal pigment epithelial cells with increasing concentrations of TNF-alpha. A similar pattern of AR promoter response was observed between TNF-alpha and osmotically stressed human liver cells. The deletion of the osmotic response element (ORE) abolished the induction by TNF-alpha and osmotic stress. A point mutation that converts ORE to a nuclear factor-kappaB (NF-kappaB) sequence abolished the osmotic response but maintained the TNF-alpha response. Electrophoretic gel mobility shift assays showed two NF-kappaB proteins, p50 and p52, capable of binding ORE sequence, and gel shift Western assay detected NF-kappaB proteins p50 and p65 in the ORE complex. Inhibitors of NF-kappaB signaling, lactacystin, and MG132 abolished the AR promoter response to TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10075698     DOI: 10.1074/jbc.274.12.7993

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Inactivation of TNF-α ameliorates diabetic neuropathy in mice.

Authors:  Isamu Yamakawa; Hideto Kojima; Tomoya Terashima; Miwako Katagi; Jiro Oi; Hiroshi Urabe; Mitsuru Sanada; Hiromichi Kawai; Lawrence Chan; Hitoshi Yasuda; Hiroshi Maegawa; Hiroshi Kimura
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-08-02       Impact factor: 4.310

2.  Regulation of chemokine expression by NaCl occurs independently of cystic fibrosis transmembrane conductance regulator in macrophages.

Authors:  Amanda G Kostyk; Karen M Dahl; Murry W Wynes; Laurie A Whittaker; Daniel J Weiss; Roberto Loi; David W H Riches
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

3.  Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models.

Authors:  Johann E Gudjonsson; Jun Ding; Andrew Johnston; Trilokraj Tejasvi; Andrew M Guzman; Rajan P Nair; John J Voorhees; Goncalo R Abecasis; James T Elder
Journal:  J Invest Dermatol       Date:  2010-03-11       Impact factor: 8.551

4.  Gene expression profiling of diabetic and galactosaemic cataractous rat lens by microarray analysis.

Authors:  E Kubo; D P Singh; Y Akagi
Journal:  Diabetologia       Date:  2005-03-11       Impact factor: 10.122

5.  Aldose reductase mediates endotoxin-induced production of nitric oxide and cytotoxicity in murine macrophages.

Authors:  Kota V Ramana; Aramati B M Reddy; Ravinder Tammali; Satish K Srivastava
Journal:  Free Radic Biol Med       Date:  2007-01-24       Impact factor: 7.376

6.  Identification of biochemical pathways for the metabolism of oxidized low-density lipoprotein derived aldehyde-4-hydroxy trans-2-nonenal in vascular smooth muscle cells.

Authors:  S Srivastava; D J Conklin; S Q Liu; N Prakash; P J Boor; S K Srivastava; A Bhatnagar
Journal:  Atherosclerosis       Date:  2001-10       Impact factor: 5.162

7.  Aldose reductase inhibition prevents endotoxin-induced uveitis in rats.

Authors:  Umesh C S Yadav; Satish K Srivastava; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

8.  Amelioration of acute kidney injury in lipopolysaccharide-induced systemic inflammatory response syndrome by an aldose reductase inhibitor, fidarestat.

Authors:  Kazunori Takahashi; Hiroki Mizukami; Kosuke Kamata; Wataru Inaba; Noriaki Kato; Chihiro Hibi; Soroku Yagihashi
Journal:  PLoS One       Date:  2012-01-12       Impact factor: 3.240

9.  Functional analysis of an arthritogenic synovial fibroblast.

Authors:  Vassilis Aidinis; David Plows; Sylva Haralambous; Maria Armaka; Petros Papadopoulos; Maria Zambia Kanaki; Dirk Koczan; Hans Juergen Thiesen; George Kollias
Journal:  Arthritis Res Ther       Date:  2003-03-14       Impact factor: 5.156

Review 10.  Protein glutathionylation in cardiovascular diseases.

Authors:  Anna Pastore; Fiorella Piemonte
Journal:  Int J Mol Sci       Date:  2013-10-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.